Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Importers Notice of Application - 2020

[Federal Register Volume 85, Number 77 (Tuesday, April 21, 2020)]
[Notices]
[Pages 22178-22179]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08354]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-606]

Importer of Controlled Substances Application: Sigma Aldrich Co., LLC

ACTION: Notice of application.


DATES: Registered bulk manufacturer of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 21, 2020. Such persons may also file a written request for a hearing on the application on or before May 21, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on January 27, 2020, Sigma Aldrich Co., LLC, 3500 DeKalb Street, Saint Louis, Missouri 63118 applied to be registered as an importer of the following basic class(es) of controlled substances:

Controlled Substance Drug Code Schedule
Cathinone 1235 I
Methcathinone 1237 I
Mephedrone (4-Methyl-N-methylcathinone) 1248 I
Gamma Hydroxybutyric Acid 2010 I
Tetrahydrocannabinols 7370 I
4-Bromo-2,5-dimethoxyamphetamine 7391 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
2,5-Dimethoxyamphetamine 7396 I
3,4-Methylenedioxyamphetamine 7400 I
3,4-Methylenedioxy-N-ethylamphetamine 7404 I
3,4-Methylenedioxymethamphetamine 7405 I
4-Methoxyamphetamine 7411 I
Dimethyltryptamine 7435 I
N-Benzylpiperazine 7493 I
Heroin 9200 I
Normorphine 9313 I
Amobarbital 2125 II
Secobarbital 2315 II
Nabilone 7379 II
Phencyclidine 7471 II
Ecgonine 9180 II
Ethylmorphine 9190 II
Levorphanol 9220 II
Meperidine 9230 II
Thebaine 9333 II
Opium, powdered 9639 II
Levo-alphacetylmethadol 9648 II

[[Page 22179]]

The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import synthetic tetrahydrocannabinols. No other activities for these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.

[FR Doc. 2020-08354 Filed 4-20-20; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility